We thank Dr James for his interest in our paper. He presents us with three separate observations, and challenges us to explain these in terms of our hypothesis (that gender-specific genes are responsible for the gender difference in birthweight). We deal with each in turn below.
First, he suggests that the gender difference in birthweight is reduced in women with pre-gestational insulin-treated diabetes, compared with the typical values he cites with respect to single live births. Male and female offspring of such women inherit a gene pool that is likely to be distinct from that of the general population; in general, they will be genetically more insulin resistant. It is possible that the genes affecting insulin sensitivity inherited by these offspring may result in a smaller gender difference in genetic insulin resistance, and hence a smaller gender difference in birthweight.
Second, he cites a 1974 paper showing that the gender difference in birthweight increases with parity. Age also increases with parity. As mothers age, they tend to acquire adiposity and with this become more insulin resistant. This will be associated with increasing glycaemia. The final prediction of the gender insulin hypothesis was amplification of the gender difference in birthweight of unaffected offspring of MODY mothers (because of maternal hyperglycaemia). In just the same way, we would predict that as maternal glycaemia rises with age (and parity), the gender difference in birthweight should increase. The Avon Longitudinal Study of Parents and Children (ALSPAC) is a cohort of 14 000 UK children in which this could prediction could be tested.
Finally, the sex ratio of infants born with intra-uterine growth retardation (IUGR) is significantly less than one would predict on the basis of population demographics, that is, fewer males are born with IUGR than expected, even when sex-specific birthweight criteria are used. The predictions of the gender insulin hypothesis apply to the general population. IUGR is associated with a range of factors other than insulin resistance, including those that affect placental function. We would not seek to use our hypothesis to explain this observation.
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